AKRO - Akero Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - AKRO (1744659)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
23 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2020-02-10
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$27.07-10,0263,233,6710%-$271,399
2020-02-06
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$27.03-6,1023,233,6970%-$164,955
M
2020-02-04
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$25.77-82,3393,239,799-2%-$2,121,726
M
2020-01-16
AKROVersant Venture Capital Vi, L.P.10%S - Sale$20.87-59,5323,092,698-2%-$1,242,403
M
2020-01-10
AKROVersant Venture Capital Vi, L.P.10%S - Sale$20.04-50,8373,152,230-2%-$1,018,571
2020-01-13
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$20.23-494,0003,322,138-13%-$9,993,620
2020-01-08
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$19.86-15,6773,816,1380%-$311,355
M
2020-01-07
AKROVersant Venture Capital Vi, L.P.10%S - Sale$19.99-53,0573,203,067-2%-$1,060,845
M
2020-01-06
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$19.86-73,2213,831,815-2%-$1,454,530
M
2020-01-02
AKROVersant Venture Capital Vi, L.P.10%S - Sale$19.70-72,4443,256,124-2%-$1,427,272
M
2020-01-02
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$19.71-35,4983,905,036-1%-$699,721
2019-12-31
AKROVenbio Global Strategic Fund II L.P.10%S - Sale$23.96-14,3243,940,5340%-$343,259
AM
2019-12-27
AKROVersant Venture Capital Vi, L.P.10%S - Sale$24.20-389,3823,656,585-10%-$9,421,175
M
2019-12-27
AKROVersant Venture Capital Vi, L.P.10%S - Sale$24.20-389,3823,656,585-10%-$9,421,175
M
2019-12-20
AKROVersant Venture Capital Vi, L.P.10%S - Sale$21.34-49,2204,045,967-1%-$1,050,416
M
2019-12-17
AKROVersant Venture Capital Vi, L.P.10%S - Sale$19.56-9,6714,095,1870%-$189,197
D
2019-06-24
AKROBitterman KevinDirP - Purchase$16.00+270,000505,099+115%+$4,320,000
D
2019-06-24
AKROAtlas Venture Fund Xi, L.P.10%P - Purchase$16.00+270,000505,099+115%+$4,320,000
D
2019-06-24
AKRORoyston AaronDirP - Purchase$16.00+250,0003,954,858+7%+$4,000,000
D
2019-06-24
AKROVersant Venture Capital Vi, L.P.10%P - Purchase$16.00+400,0004,104,858+11%+$6,400,000
D
2019-06-24
AKROHarrison Seth LoringDir, 10%P - Purchase$16.00+900,0005,415,203+20%+$14,400,000
D
2019-06-24
AKROApple Tree Partners Iv, L.P.10%P - Purchase$16.00+900,0005,415,203+20%+$14,400,000
D
2019-06-24
AKROVenbio Global Strategic Fund II L.P.10%P - Purchase$16.00+250,0003,954,858+7%+$4,000,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top